A099430 Stock Overview
Engages in the research and development, production, and sale of bio products in South Korea.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Bio Plus Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩5,950.00 |
52 Week High | ₩8,470.00 |
52 Week Low | ₩4,250.00 |
Beta | 0.80 |
11 Month Change | -6.74% |
3 Month Change | 21.55% |
1 Year Change | -24.87% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -26.66% |
Recent News & Updates
Earnings Not Telling The Story For Bio Plus Co., Ltd (KOSDAQ:099430) After Shares Rise 29%
Jul 23The Returns On Capital At Bio Plus (KOSDAQ:099430) Don't Inspire Confidence
Jul 05Recent updates
Earnings Not Telling The Story For Bio Plus Co., Ltd (KOSDAQ:099430) After Shares Rise 29%
Jul 23The Returns On Capital At Bio Plus (KOSDAQ:099430) Don't Inspire Confidence
Jul 05More Unpleasant Surprises Could Be In Store For Bio Plus Co., Ltd's (KOSDAQ:099430) Shares After Tumbling 31%
Jun 08Additional Considerations Required While Assessing Bio Plus' (KOSDAQ:099430) Strong Earnings
Mar 26Shareholder Returns
A099430 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -9.6% | 6.4% | 2.9% |
1Y | -24.9% | 26.6% | 4.4% |
Return vs Industry: A099430 underperformed the KR Medical Equipment industry which returned 26.6% over the past year.
Return vs Market: A099430 underperformed the KR Market which returned 4.4% over the past year.
Price Volatility
A099430 volatility | |
---|---|
A099430 Average Weekly Movement | 7.6% |
Medical Equipment Industry Average Movement | 8.1% |
Market Average Movement | 6.5% |
10% most volatile stocks in KR Market | 12.1% |
10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A099430's share price has been volatile over the past 3 months.
Volatility Over Time: A099430's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 84 | Hyun-Kyu Jung | www.ubioplus.co.kr |
Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms.
Bio Plus Co., Ltd Fundamentals Summary
A099430 fundamental statistics | |
---|---|
Market cap | ₩340.27b |
Earnings (TTM) | ₩21.79b |
Revenue (TTM) | ₩62.25b |
15.6x
P/E Ratio5.5x
P/S RatioIs A099430 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A099430 income statement (TTM) | |
---|---|
Revenue | ₩62.25b |
Cost of Revenue | ₩24.61b |
Gross Profit | ₩37.63b |
Other Expenses | ₩15.85b |
Earnings | ₩21.79b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 380.97 |
Gross Margin | 60.46% |
Net Profit Margin | 35.00% |
Debt/Equity Ratio | 8.4% |
How did A099430 perform over the long term?
See historical performance and comparison